The role of metabolic syndrome in the development of polycystic ovary syndrome in adolescence

被引:0
|
作者
Avramenko, N. V. [1 ,2 ]
Kabachenko, O. V. [2 ]
Barkovskyi, D. Ye. [2 ]
Sierykh, K. V. [2 ]
机构
[1] Zaporizhzhia State Med & Pharmaceut Univ, Fac Postgrad Educ, Zaporizhia, Ukraine
[2] Zaporizhzhia State Med & Pharmaceut Univ, Fac Postgrad Educ, Dept Obstet Gynecol & Reprod Med, Zaporizhia, Ukraine
关键词
obesity; metabolic syndrome; polycystic ovary syndrome; adolescence; diagnosis; treatment; prevention; ASSOCIATIONS; MANAGEMENT; OBESITY; HEALTH; RISK;
D O I
10.14739/2310-1210.2023.3.251479
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The review article presents an analysis of the metabolic syndrome problem in children and adolescents, its role in the development of polycystic ovary syndrome (PCOS) in accordance with the latest International guidelines and modern literature. The urgency of the problem lies in the rapid spread of overweight among children in the world and, consequently, the growth of alimentary -de-pendent pathology. One of the major consequences of weight problems is metabolic syndrome (MS). There are still no clear MS criteria for children and adolescents. IDF suggests using IDF criteria for adults. Priority in the pathogenesis of MS is given to insulin resistance (IR), which is associated with puberty. The problem of IR assessment remains. HOMA-IR and QUICKI methods are not considered reliable tests to determine IR, so the assessment is based on clinical signs (hyperglycemia, dyslipidemia, abdominal obesity, hypertension). Obesity and IR can be predictors of PCOS, which can often be associated with puberty. Pathological signs of the syndrome ty-pical for adults in adolescence may be a manifestation of the physiological course of puberty. Obligative criteria for the diagnosis of PCOS in adolescence are irregular menstruation/oligomenorrhea, proven biochemically and clinically hyperandrogenemia). First-line therapy for PCOS in adolescents with MS is weight loss and dosed exercise, which helps to normalize a hormonal balance. Drug treatment may include insulin-sensitizing drugs (metformin), antiandrogens (spironlactone, flutamide, cyproterone acetate), 5-alpha-reductase inhibitors (finasteride), combined oral contraceptives, inositol. Prevention of overweight, obesity in children can prevent the development of IR and, accordingly, associated MS and PCOS, reproductive health disorders. Prevention measures are aimed at avoiding maternal obesity, gestational diabetes, malnutrition and smoking during pregnancy, promoting breastfeeding and physical activity.
引用
收藏
页码:255 / 261
页数:7
相关论文
共 50 条
  • [31] Challenges in diagnosis of polycystic ovary syndrome in adolescence
    Asanidze, Elene
    Kristesashvili, Jenaro
    Parunashvili, Nino
    Karelishvili, Natalia
    Etsadashvili, Nana
    GYNECOLOGICAL ENDOCRINOLOGY, 2021, 37 (09) : 819 - 822
  • [32] Diagnosis and Challenges of Polycystic Ovary Syndrome in Adolescence
    Agapova, Sophia E.
    Cameo, Tamara
    Sopher, Aviva B.
    Oberfield, Sharon E.
    SEMINARS IN REPRODUCTIVE MEDICINE, 2014, 32 (03) : 194 - 201
  • [33] Polycystic ovary syndrome in adolescence - a therapeutic conundrum
    Homburg, R
    Lambalk, CB
    HUMAN REPRODUCTION, 2004, 19 (05) : 1039 - 1042
  • [34] Management of Polycystic Ovary Syndrome in Childhood and Adolescence
    Ojaniemi, M.
    Tapanainen, P.
    Morin-Papunen, L.
    HORMONE RESEARCH IN PAEDIATRICS, 2010, 74 (05): : 372 - 375
  • [35] Contribution of hyperandrogenism to the development of metabolic syndrome in obese women with polycystic ovary syndrome
    Benevides Rehme, Marta Francis
    Pontes, Ana Gabriela
    Corrente, Jose Eduardo
    Franco, Jose Goncalves, Jr.
    Pontes, Anagloria
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2013, 35 (12): : 562 - 568
  • [36] The Diagnosis of Polycystic Ovary Syndrome during Adolescence
    Witchel, Selma F.
    Oberfield, Sharon
    Rosenfield, Robert L.
    Codner, Ethel
    Bonny, Andrea
    Ibanez, Lourdes
    Pena, Alexia
    Horikawa, Reiko
    Gomez-Lobo, Veronica
    Joel, Dipesalema
    Tfayli, Hala
    Arslanian, Silva
    Dabadghao, Preeti
    Rudaz, Cecilia Garcia
    Lee, Peter A.
    HORMONE RESEARCH IN PAEDIATRICS, 2015, 83 (06): : 376 - 389
  • [37] Optimal management of polycystic ovary syndrome in adolescence
    Baldauff, Natalie Hecht
    Arslanian, Silva
    ARCHIVES OF DISEASE IN CHILDHOOD, 2015, 100 (11) : 1076 - 1083
  • [38] Screening women with polycystic ovary syndrome for metabolic syndrome
    Dokras, A
    Bochner, M
    Hollinrake, E
    Markham, S
    VanVoorhis, B
    Jagasia, DH
    OBSTETRICS AND GYNECOLOGY, 2005, 106 (01): : 131 - 137
  • [39] The metabolic effects of polycystic ovary syndrome
    Bednarek-Tupikowska, Grazyna
    Bucyk, Barbara
    FAMILY MEDICINE AND PRIMARY CARE REVIEW, 2008, 10 (03): : 769 - 774
  • [40] Polycystic ovary syndrome, adipose tissue and metabolic syndrome
    Alessandro P. Delitala
    Giampiero Capobianco
    Giuseppe Delitala
    Pier Luigi Cherchi
    Salvatore Dessole
    Archives of Gynecology and Obstetrics, 2017, 296 : 405 - 419